PitchSend

Popular
Blog
Companies
Finance
Technology
Banking
Information Technology
Oil and Energy
Internet
Mining and Metals
Communications
Real Estate
Biotechnology
Automotive
Medical
Retail
Energy
Nuvectis Pharma Investor Presentation Deck slide image

Nuvectis Pharma Investor Presentation Deck

NXP900 Kinome Profiling Demonstrates High Selectivity NuvectisPharma, Inc. TK CMGC NXP900 CAMK TKL STE CK1 AGC TK CMGC Dasatinib CAMK TKL Note: Dasatinib data from Remsing Rix et al., Leukemia 23, 477-485 (2009), NXP900 data from AACR 2022. STE CK1 AGC 15
View entire presentation

Product

HomeSearchAccount

Categories

Finance PresentationsTechnology PresentationsBanking PresentationsInformation Technology PresentationsOil and Energy PresentationsInternet PresentationsMining and Metals PresentationsCommunications PresentationsReal Estate PresentationsBiotechnology PresentationsAutomotive PresentationsMedical PresentationsRetail PresentationsEnergy Presentations

Company

InsightsContactSupport

Legal

Terms of ServicePrivacy Policy

Connect

TwitterLinkedInInstagramYouTube